Tamiflu correspondence with the European ombudsman


In October 2012 Cochrane Collaboration researcher Tom Jefferson made a maladministration complaint to the European Ombudsman. In his letter, displayed below, he says the European Medicines Agency issued a market authorisation for oseltamivir on 20 June 2002. The EMA do not have and have never had a complete evidence set, he says.

 

 

All rapid responses

Rapid responses are electronic letters to the editor. They enable our users to debate issues raised in articles published on bmj.com. Although a selection of rapid responses will be included as edited readers' letters in the weekly print issue of the BMJ, their first appearance online means that they are published articles. If you need the url (web address) of an individual response, perhaps for citation purposes, simply click on the response headline and copy the url from the browser window.

Tom Jefferson's complaint to the European Ombudsman, submitted on 15 October 2012.

Competing interests: No competing interests

13 November 2012
Tom Jefferson
Researcher
Cochrane Collaboration
Rome
Click to like:
66
Vote down!